Patents by Inventor Kevin George Kelly

Kevin George Kelly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030069699
    Abstract: A method and device for the automated large scale preparation for testing of drug-drug interactions, particularly with determination of IC50 and Ki, as a screening tool enhancement for determining viability of large numbers of compounds as drug candidates. Small samples of specific probe substrates and new compound inhibitors are automatically dispensed en masse into multi-welled reaction plates which are prefilled with thawed human microsomes, buffer and cofactor. The reaction plates are incubated and the reaction products are tested within degradation time limits, for initial biological determinations of relevant interaction effects of the compounds.
    Type: Application
    Filed: October 29, 2002
    Publication date: April 10, 2003
    Inventors: Sean Ekins, Diane Lynn Johnson, Kevin George Kelly
  • Patent number: 6489094
    Abstract: A method and device for the automated large scale preparation for testing of drug-drug interactions, particularly with determination of IC50 and Ki, as a screening tool enhancement for determining viability of large numbers of compounds as drug candidates. Small samples of specific probe substrates and new compound inhibitors are automatically dispensed en masse into multi-welled reaction plates which are prefilled with thawed human microsomes, buffer and cofactor. The reaction plates are incubated and the reaction products are tested within degradation time limits, for initial biological determinations of relevant interaction effects of the compounds.
    Type: Grant
    Filed: May 16, 2001
    Date of Patent: December 3, 2002
    Assignee: Pfizer Inc.
    Inventors: Sean Ekins, Diane Lynn Johnson, Kevin George Kelly
  • Publication number: 20010049092
    Abstract: A method and device for the automated large scale preparation for testing of drug-drug interactions, particularly with determination of IC50 and Ki, as a screening tool enhancement for determining viability of large numbers of compounds as drug candidates. Small samples of specific probe substrates and new compound inhibitors are automatically dispensed en masse into multi-welled reaction plates which are prefilled with thawed human microsomes, buffer and cofactor. The reaction plates are incubated and the reaction products are tested within degradation time limits, for initial biological determinations of relevant interaction effects of the compounds.
    Type: Application
    Filed: May 16, 2001
    Publication date: December 6, 2001
    Applicant: Pfizer Inc.
    Inventors: Sean Ekins, Diane Lynn Johnson, Kevin George Kelly